Delivery Order SPE2DB20D1109-SPE2DB21FP85C
- Not listed
- This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $3,764.40, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 27, 2022, with a completion date of January 28, 2022. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials. The $2,891.97 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which enables the efficient procurement of a wide range of pharmaceutical products and medical supplies to support...
- This federal contract award is for the delivery of Feraheme 510 mg/17 ml vials to the Defense Logistics Agency (DLA). The $4,011.53 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2022, with an ultimate completion date of August 11, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of Feraheme (ferumoxytol) 510 mg/17 ml vials to the U.S. government. The contract, valued at $7,212.20, was awarded on July 29, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of August 1, 2022. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution...
- This federal contract award, valued at $2,895.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the pharmaceutical product Feraheme 510 mg/17 ml vial, with a performance period extending through May 7, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Ferumoxytol 510 mg/17 ml vial, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $21,108.26 and a completion date of June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,298.26, is for the delivery of 4566197516 - FERAHEME 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,484.75 firm fixed-price delivery order is for the supply of Ferumoxytol 510 mg/17 ml vials. The contract has a period of performance through July 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $7,837.81 to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 mL vials on November 13, 2025, with an ultimate completion date of November 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FP85CDelivery Order
This federal contract award is for the delivery of Feraheme (ferumoxytol) 510 mg/17 mL vials to the Defense Logistics Agency (DLA). The $3,913.10 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on August 23, 2021, with an ultimate completion date of August 24, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00 and $750,000.00 respectively. These IDCs enable Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support military, veteran, and other federal healthcare programs. The contract award reviewed does not have a set-aside designation, indicating full and open competition.